首页> 美国卫生研究院文献>Cannabis and Cannabinoid Research >Training and Practices of Cannabis Dispensary Staff
【2h】

Training and Practices of Cannabis Dispensary Staff

机译:大麻药房人员的培训和实践

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Introduction: The proliferation of cannabis dispensaries within the United States has emerged from patient demand for the legalization of cannabis as an alternative treatment for a number of conditions and symptoms. Unfortunately, nothing is known about the practices of dispensary staff with respect to recommendation of cannabis strains/concentrations for specific patient ailments. To address this limitation, the present study assessed the training and practices of cannabis dispensary staff.>Materials and Methods: Medical and nonmedical dispensary staff (n=55) were recruited via e-mail and social media to complete an online survey assessing their demographic characteristics, dispensary features, patient characteristics, formal training, and cannabis recommendation practices.>Results: Fifty-five percent of dispensary staff reported some formal training for their position, with 20% reporting medical/scientific training. A majority (94%) indicated that they provide specific cannabis advice to patients. In terms of strains, dispensary staff trended toward recommendations of Indica for anxiety, chronic pain, insomnia, nightmares, and Tourette's syndrome. They were more likely to recommend Indica and hybrid plants for post-traumatic stress disorder (PTSD)/trauma and muscle spasms. In contrast, staff were less likely to recommend Indica for depression; hybrid strains were most often recommended for amyotrophic lateral sclerosis (ALS). In terms of cannabinoid concentrations, dispensary staff were most likely to recommend a 1:1 ratio of delta-9-tetrahydrocannabinol (THC):cannabidiol (CBD) for patients suffering from anxiety, Crohn's disease, hepatitis C, and PTSD/trauma, while patients seeking appetite stimulation were most likely to be recommended THC. Staff recommended high CBD for arthritis and Alzheimer's disease and a high CBD or 1:1 ratio for ALS, epilepsy, and muscle spasms.>Conclusions: Although many dispensary staff are making recommendations consistent with current evidence, some are recommending cannabis that has either not been shown effective for, or could exacerbate, a patient's condition. Findings underscore the importance of consistent, evidence-based, training of dispensary staff who provide specific recommendations for patient medical conditions.
机译:>简介:在美国,大麻药房的兴起源于患者对大麻合法化的需求,这是对多种疾病和症状的替代治疗。不幸的是,对于针对特定患者疾病的大麻菌株/浓度推荐,药房人员的做法一无所知。为了解决这一局限性,本研究评估了大麻药房人员的培训和做法。>材料和方法:通过电子邮件和社交媒体招募了55名医疗和非医疗药房人员一项在线调查,评估其人口统计学特征,药房特征,患者特征,正规培训和大麻推荐做法。>结果: 55%的药房工作人员报告了其职位的正规培训,其中20%的报告医学/科学训练。多数(94%)表示他们向患者提供具体的大麻建议。在压力方面,药房工作人员倾向于推荐In,焦虑,慢性疼痛,失眠,噩梦和图雷特氏综合症。他们更有可能推荐印度and和杂种植物治疗创伤后应激障碍(PTSD)/创伤和肌肉痉挛。相比之下,工作人员不太可能推荐使用印度苦depression。杂种菌株最常推荐用于肌萎缩性侧索硬化症(ALS)。在大麻素浓度方面,对于焦虑,克罗恩病,丙型肝炎和PTSD /创伤的患者,药房工作人员最有可能建议1:1比例的delta-9-四氢大麻酚(THC):cannabidiol(CBD)寻求食欲刺激的患者最有可能被推荐使用THC。工作人员建议关节炎和阿尔茨海默氏病的CBD值较高,而ALS,癫痫和肌肉痉挛的CBD值或1:1的比例较高。>结论:尽管许多药房人员在提出与当前证据相符的建议,但有些建议推荐尚未证明对病情有效或可能加重病情的大麻。调查结果强调了对提供针对患者医疗状况的具体建议的药房人员进行一致的,循证的培训的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号